Texas Cannabis Sales

Among small-tier U.S. cannabis markets, Texas posted one of the sharpest year-over-year jumps at 105.3%, driven by patient growth across just 13 dispensaries. The two-year gain of 32.1% is notable given the state's restrictive licensing framework, though falling prices suggest that supply is beginning to outpace demand within the narrow patient pool. Store count expanded 18.2% year over year, a meaningful increase for a market where new dispensary openings require legislative or regulatory action.

24-Month Trend

State	Sales	YoY
Locked State	$XX-XXM	XX.X%
Kentucky	$2.5-5M	1625.0%
Locked State	$XX-XXM	XX.X%
North Dakota	$1-2.5M	13.1%
Locked State	$XX-XXM	XX.X%

Unlock The Full Table

Log in to unlock the full market comparison table and image export for this section.

Log in to unlockOpen app

Benchmarking

Market ComparisonOct 2026

Among small-tier U.S. cannabis markets, Texas posted one of the sharpest year-over-year jumps at 105.3%, driven by patient growth across just 13 dispensaries. The two-year gain of 32.1% is notable given the state's restrictive licensing framework, though falling prices suggest that supply is beginning to outpace demand within the narrow patient pool. Store count expanded 18.2% year over year, a meaningful increase for a market where new dispensary openings require legislative or regulatory action.

24-Month Trend

State	Sales	YoY
Hawaii	$2.5-5M	-2.8%
Kentucky	$2.5-5M	+1625.0%
Texas	$2.5-5M	-4.4%
North Dakota	$1-2.5M	+13.1%
Yukon	$1-2.5M	+3.5%

Top performing dispensaries in Texas.

Swipe to see more →

Store	City	Est. Sales
#1 Fluent - Schulenburg	Schulenburg	<$250K

Topicals exploded at 447.2% year-over-year growth, the fastest-moving category in the Texas market, though they still account for only 5.1% of total share. Edibles hold the largest slice at 52.6%, doubling year over year, while oral products—at 42.2% share and 137.8% growth—are gaining ground quickly under Texas Original's product lineup. Concentrates disappeared entirely from tracked sales, falling 100% year over year, leaving the market almost exclusively split between ingestible formats as patients gravitate toward edibles and tinctures within the state's low-THC framework.

Swipe to see more →

Category	Sales	Avg Price	YoY
#1Oral	$1-2.5M	$83.87	35.5%
#2Edibles	$.5M-1M	$28.63	54.7%
#3Vapes	$.5M-1M	$47.17	854.6%
#4Concentrates	<$250K	$45.25	303.0%
#5Topicals	<$250K	$27.93	46.8%
#6Accessories	<$250K	$15.44	413.4%
#7Flower	<$250K	$51.99	37.9%
#8Pre-Rolls	<$250K	$15	37.9%